Results 21 to 30 of about 19,494 (244)

Fractional exhaled nitric oxide and forced expiratory flow between 25% and 75% of vital capacity in children with controlled asthma [PDF]

Korean Journal of Pediatrics, 2012
PurposeFractional exhaled nitric oxide (FeNO) and forced expiratory flow between 25% and 75% of vital capacity (FEF25-75) are not included in routine monitoring of asthma control.
Ji-Yong Yoon, Sung-Il Woo, Heon Kim, Yong-Han Sun, Youn-Soo Hahn   +4 more
doaj   +1 more source

Exploring the Interaction between Fractional Exhaled Nitric Oxide and Biologic Treatment in Severe Asthma: A Systematic Review

Antioxidants, 2023
Background: Fractional exhaled nitric oxide (FeNO) is a biomarker of airway inflammation associated with airway hyper-responsiveness and type-2 inflammation.
Tommaso Pianigiani, Lorenzo Alderighi, Martina Meocci, Maddalena Messina, Beatrice Perea, Simona Luzzi, Laura Bergantini, Miriana D’Alessandro, Rosa Metella Refini, Elena Bargagli, Paolo Cameli   +10 more
doaj   +1 more source

Determinants of Children's Exhaled Nitric Oxide: New Insights from Quantile Regression. [PDF]

PLoS ONE, 2015
While the fractional concentration of exhaled nitric oxide (FeNO) has proven useful in asthma research, its exact role in clinical care remains unclear, in part due to unexplained inter-subject heterogeneity.
Yue Zhang, Kiros Berhane, Sandrah P Eckel, Muhammad T Salam, William S Linn, Edward B Rappaport, Theresa M Bastain, Frank D Gilliland   +7 more
doaj   +1 more source

feno

, 2023
 According to the FeNO value at the first visit, the subjects were divided into different high- and low-FeNO groups according to the ATS guidelines and the Chinese multicenter study recommendations.  
Qiuyan Yang (14760943)
core   +1 more source

CORELAŢIA DINTRE VALOAREA FENO ŞI SEVERITATEA ASTMULUI BRONŞIC [PDF]

Romanian Journal of Pediatrics, 2014
Obiectiv. Studiul de faţă îşi propune evaluarea corelaţiei dintre valoare FeNO şi severitatea astmului bronşic. Material şi metodă. A fost iniţiat un studiu prospectiv care a inclus 48 de copii cu vârsta cuprinsă între 5-18 ani diagnosticaţi cu astm ...
Eugenia Buzoianu, Mariana Moiceanu, Doina Anca Pleşca   +2 more
doaj   +1 more source

Combination of Fractional Exhaled Nitric Oxide (FeNO) Level and Asthma Control Test (ACT) in Detecting GINA-Defined Asthma Control in Treated Asthmatic Patients in Vietnam

Canadian Respiratory Journal, 2020
Background. FeNO has been used as a marker for Th2-mediated airway inflammation in asthma. There is evidence which recommends the use of this biomarker in asthma management. Little is known about whether the FeNO test alone or in combination with the ACT
Vinh Nguyen Nhu, Pham Le An, Niels H. Chavannes   +2 more
doaj   +1 more source

672 Feno and Asthma Control [PDF]

Archives of Disease in Childhood, 2012
Background and Aims Asthma is a chronic inflammatory disease of the lower airways, whose treatment is conducted by guidelines in use, depending on clinical markers of disease control (ACT=asthma control test score) and spirometric values. Due to situations in which there is discrepancy between the two categories of parameters, we aimed this study to ...
F. Cora, M. Moiceanu, E. Buzoianu, V. Hurduc, D. Plesca   +4 more
openaire   +1 more source

Randomised controlled trials utilising FENO to manage asthma: is it time to acknowledge that “one size does not fit all”? (Editorial)

, 2022
In the current issue of the European Respiratory Journal, MURPHY et al. [1] report the effects of managing asthma based on fractional exhaled nitric oxide (FENO) on perinatal outcomes.
Petsky, Helen
core   +1 more source

Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin

Lipids in Health and Disease, 2011
Background Fibrates have been reported to cause paradoxical decreases in HDL-C in certain patients. Design and methods This post-hoc analysis explored the frequency/magnitude of HDL-C reductions in a pooled database of mixed dyslipidemic patients (LDL-C ...
Farnier Michel, Dong Qian, Shah Arvind, Johnson-Levonas Amy O, Brudi Philippe   +4 more
doaj   +1 more source

A Nonheme Sulfur‐Ligated {FeNO}⁶ Complex and Comparison with Redox‐Interconvertible {FeNO}⁷ and {FeNO}⁸ Analogues

Angewandte Chemie International Edition, 2018
AbstractA nonheme {FeNO}6 complex, [Fe(NO)(N3PyS)]2+, was synthesized by reversible, one‐electron oxidation of an {FeNO}7 analogue. This complex completes the first known series of sulfur‐ligated {FeNO}6–8 complexes. All three {FeNO}6–8 complexes are readily interconverted by one‐electron oxidation/reduction. A comparison of spectroscopic data (UV/Vis,
Aniruddha Dey, Alex M. Confer, Avery C. Vilbert, Pierre Moënne‐Loccoz, Kyle M. Lancaster, David P. Goldberg   +5 more
openaire   +4 more sources